Shanghai MicuRx advances MRX-4 trial results towards NDA approval
Shanghai MicuRx Pharmaceutical Co., Ltd. has announced a major breakthrough in antibacterial drug development, successfully completing its Phase III clinical trial of MRX-4 for injection ... Read More
Cipla Therapeutics partners with SIGA Technologies for antibacterial drugs
Cipla Therapeutics, an Indian pharma company, and SIGA Technologies have entered into a partnership to provide sustained innovation and access to novel antibacterial drugs, especially ... Read More